Investors looking to juice their healthcare profits can consider the Direxion Daily Healthcare Bull 3x Shares (NYSEArca: CURE), the triple-leveraged answer to XLV. Although conventional wisdom dictates leveraged ETFs should not be held for long periods, CURE has gone above and beyond in terms of delivering triple XLV’s returns over the past year, surging 91.6%.
CURE was recently split 4-for-1, giving it a more approachable price tag of just under $40 at Wednesday’s close.
Health Care Select Sector SPDR
Chart Courtesy: Kimble Charting Solutions